FLDM - Fluidigm Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Fluidigm Corporation

7000 Shoreline Court
Suite 100
South San Francisco, CA 94080
United States
650-266-6000
http://www.fluidigm.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees505

Key Executives

NameTitlePayExercisedYear Born
Mr. Stephen Christopher LinthwaitePres, CEO & Director960.01kN/A1973
Mr. Vikram JogCFO & Principal Accounting OfficerN/AN/A1956
Mr. Nicholas S. KhadderSr. VP, Gen. Counsel & Corp. Sec.482.95kN/A1974
Mr. Steven C. McPhailChief Commercial Officer488.4kN/A1954
Ms. Mai Chan YowMD of Fluidigm Singapore Pte Ltd & EVP of Worldwide Manufacturing - Fluidigm Singapore Pte Ltd477.05kN/A1959
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell genomics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments and consumables, including IFCs, assays, and reagents to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

Corporate Governance

Fluidigm Corporation’s ISS Governance QualityScore as of November 1, 2018 is 9. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.